4.6 Article

Activation of hypoxia-induced transcription in normoxia

期刊

EXPERIMENTAL CELL RESEARCH
卷 306, 期 1, 页码 180-191

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2005.01.017

关键词

hypoxia; hypoxia-inducible factor; vascular endothelial growth factor; von Hippel-Lindau protein; prolyl hydroxylase

向作者/读者索取更多资源

Hypoxia-inducible factor-1 (HIF-1), the master regulator of transcriptional responses to reduced oxygen tension (hypoxia) in mammalian cells, consists of one HIF-1 alpha and one HIF-1 beta subunit. In normoxia, HIF-1 alpha subunits are hydroxylated on specific proline residues; modifications that signal ubiquitination and degradation of HIF-1 alpha by the proteasoine. To test the effect of saturating HIF-1 alpha degradation, we generated a construct, denoted the saturating domain (SD), based on a region surrounding proline 564 (Pro564) in HIF-1 alpha. Expression of the SD led to accumulation of endogenous HIF-1 alpha proteins in nuclei of nonrioxic cells. The induced HTF-1 alpha was functional as it activated expression from a hypoxia-regulated reporter gene and from the endogenous vascular endothelial growth facor-alpha (Vegf-a) and carbonic anhydrase 9 (CO) genes. The effect of the SD was dependent on Pro564 since a mutated SD, in which Pro564 had been replaced by a glycine residue, failed to bind the von Hippel-Lindau protein (pVHL) and to stabilise HIF-1 alpha. Treatment of cells with the prolylhydroxylase inhibitor dimethyloxalylglycine, or the proteasome inhibitor MG-132, mimicked the effect of the SD. In conclusion, we show that blocking HIF-1 alpha degradation, either by saturation, or inhibition of prolyl hydroxylases or proteosomal degradation, leads to nuclear localisation of active HIF-1 alpha proteins. (c) 2005 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据